PEP-Therapy
ID: 7646481Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.
1
Funding Rounds
$3.1m
Money raised
Recent Funding Rounds
Overview
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| An***** Pr***** |
|
- | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| An***** Pr***** |
|
- | - |
Funding series
Funding Series Analysis
The company PEP-Therapy has raised a total of $3.1m in funding over 1 rounds.
Key Insights:
- PEP-Therapy Series A round, July 2021: $3.1m